Brexanolone: all 27 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Brexanolone Lifting Outcomes Of MomsRecruitingNCT07822321Phase 3
- Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding StudyNot yet recruitingNCT06580444Phase 2
- Allopregnanolone in Chronic Complex Traumatic Brain InjuryNot yet recruitingNCT04003285Phase 2
- An Open-Label Study Evaluating Brexanolone in Adults With TinnitusCompletedNCT05645432Phase 2Results posted
- Study on Allopregnanolone and Depression in Perimenopausal WomenTerminatedNCT05329779Phase 4Results posted
- A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home SettingCompletedNCT05059600Phase 4Results posted
- A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)TerminatedNCT04537806Phase 3Results posted
- Effect of Allopregnanolone on Stress-induced CravingCompletedNCT04015869Phase 1Results posted
- A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)CompletedNCT03665038Phase 3Results posted
- A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)CompletedNCT02942017Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)CompletedNCT02942004Phase 3Results posted
- A Study to Evaluate SAGE-547 in Participants With Severe Postpartum DepressionCompletedNCT02614547Phase 2Results posted
- Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With AllopregnanoloneCompletedNCT02603926Phase 2Results posted
- A Study With SAGE-547 for Super-Refractory Status EpilepticusCompletedNCT02477618Phase 3Results posted
- Evaluate SAGE-547 in Female Participants With Severe Postpartum DepressionCompletedNCT02285504Phase 2Results posted
- Evaluate SAGE-547 in Participants With Essential TremorCompletedNCT02277106Phase 2Results posted
- Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status EpilepticusCompletedNCT02052739Phase 1/2Results posted
- Allopregnanolone for the Treatment of Traumatic Brain InjuryCompletedNCT01673828Phase 2Results posted
- A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDCompletedNCT06979544Phase 3
- Allopregnanolone as a Regenerative Treatment for Parkinson's DiseaseCompletedNCT06263010Phase 1
- Effects Zulresso on Postpartum PsychosisCompletedNCT05314153Early Phase 1
- An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress DisorderTerminatedNCT05254405Phase 4
- Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress DisorderActive, not recruitingNCT05223829Phase 1
- Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseaseActive, not recruitingNCT04838301Phase 2
- A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)WithdrawnNCT04273191Phase 4
- Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular StudyTerminatedNCT03748303Phase 1
- Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild ADCompletedNCT02221622Phase 1